Search | Page 3 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Overview of myelodysplastic syndromes

    ... by diagnostic entities of world renown as well as by other research groups and individuals to establish a reliable prognostic system. ... subgroups and the role of molecular markers in predicting clinical evolution. Bone Marrow ...

    Research Article last updated 07/20/2018 - 5:14pm.

  2. Genetics of myelodysplastic syndromes: new insights

    ... contribute to disease pathogenesis is an active area of research, with a current focus on which downstream target genes may be ... are sufficiently robust to be incorporated into routine clinical practice at this time. Additional studies will be required to ...

    Research Article last updated 07/20/2018 - 5:14pm.

  3. Prognostic value of self-reported fatigue on overall survival in patients with myelodysplastic syndromes: a multicentre, prospective, observational, cohort study

    ... BACKGROUND: The clinical presentation of myelodysplastic syndromes is highly variable ... IPSS and fatigue score from the European Organisation for Research and Treatment of Cancer quality-of-life questionnaire-core 30, ...

    Research Article last updated 07/20/2018 - 5:15pm.

  4. Beyond hypomethylating agents failure in patients with myelodysplastic syndromes

    ... toxicity and relapse rates is another area of active research. SUMMARY: Sequential switching to the alternative HMA, clinical trials of novel targeted therapies, azacitidine-based combination ...

    Research Article last updated 07/20/2018 - 5:15pm.

  5. Horse versus rabbit antithymocyte globulin in acquired aplastic anemia

    ... peripheral-blood lymphocytes and is preferred in other clinical circumstances. METHODS: From December 2005 through July ... response and survival. (Funded by the Intramural Research Program of the National Institutes of Health; ClinicalTrials.gov ...

    Research Article last updated 07/20/2018 - 5:14pm.

  6. Optimizing hypomethylating agents in myelodysplastic syndromes

    ... will hopefully be modified with future results of ongoing clinical and translational research. Bone Marrow ...

    Research Article last updated 07/20/2018 - 5:14pm.

  7. MDS - Treatment (OLD)

    ... Clinical Trials Clinical research studies, also called clinical trials, are at the heart of all ...

    Topic section last updated 07/20/2018 - 5:15pm.

  8. Paroxysmal Nocturnal Hemoglobinuria (PNH)

    ... help people with PNH live longer. You may have seen older research saying that patients with PNH live an average of 15 to 20 years, but ... shot. Although case reports are not the same as randomized clinical trials, one case of hemolysis was severe enough to put the patient in ...

    Page last updated 07/20/2018 - 5:15pm.

  9. Sydney Lu, MD, PhD

    ... Original Research Center:  Sloan-Kettering Institute for Cancer ... myeloid neoplasms to further splicing inhibition has led to clinical development of drugs targeting core splicing catalysis by inhibiting ...

    Grant Recipient last updated 07/05/2018 - 11:17am.

  10. Create a Legacy – Transformative Giving

    ... unique and innovative initiative that focuses on MDS research Born on January 31, 1942, Edward Parker Evans was a graduate of ... 2012, The Edward P. Evans Foundation established the MDS Clinical Research Consortium consisting of 6 leading medical institutions ...

    Page last updated 06/29/2018 - 11:10am.